Exploring the synergy between tumor microenvironment modulation and STING agonists in cancer immunotherapy

Exploring the synergy between tumor microenvironment modulation and STING agonists in cancer immunotherapy

Saved in:

Bibliographic Details
Main Authors:	Xiaoyan Qi, Cheng Cheng, Dawei Zhang, Zongjiang Yu, Xiangwei Meng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Immunology
Subjects:	tumor microenvironment (TME) STING agonists cancer immunotherapy immune suppression macrophage polarization
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1488345/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

STING Agonists and How to Reach Their Full Potential in Cancer Immunotherapy
by: Laura Gehrcken, et al.
Published: (2025-05-01)

Progress Update on STING Agonists as Vaccine Adjuvants
by: Yanru Shen, et al.
Published: (2025-03-01)

Conjugated STING agonists
by: Shuhao Qu, et al.
Published: (2025-06-01)

A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists
by: Yu‐an Li, et al.
Published: (2025-01-01)

Photothermal therapy combined with a STING agonist induces pyroptosis, and gasdermin D could be a new biomarker for guiding the treatment of pancreatic cancer
by: Yanyan Hu, et al.
Published: (2025-03-01)

Potential therapeutic strategies for colitis and colon cancer: bidirectional targeting STING pathway
by: Jiaorong Qu, et al.
Published: (2025-01-01)

Ciprofloxacin Exerts Anti-Tumor Effects In Vivo Through cGAS-STING Activation and Modulates Tumor Microenvironment
by: Jian-Syun Chen, et al.
Published: (2025-07-01)

Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment
by: Qingyang Wang, et al.
Published: (2025-06-01)

RAW264.7 Macrophages as a Polarization Model in the Context of Pancreatic Cancer and Chemokine Release
by: Aydar Khabipov, et al.
Published: (2025-03-01)

The activation of cGAS-STING pathway offers novel therapeutic opportunities in cancers
by: Yumin Wang, et al.
Published: (2025-06-01)

Next‐Generation HER‐2 Tumor‐Targeted Delivery of the STING Agonist Immune‐Stimulating Antibody Conjugate (ISAC) Improves Anticancer Efficacy and Induces Immunological Memory
by: Gang Wu, et al.
Published: (2025-07-01)

Immunotherapy biomarkers in brain metastases: insights into tumor microenvironment dynamics
by: Mu Li, et al.
Published: (2025-08-01)

Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy
by: Qian Zeng, et al.
Published: (2025-06-01)

Epithelial and macrophage cell interaction in cervical cancer through single-cell RNA-sequencing and spatial analysis
by: Zhichao Wang, et al.
Published: (2025-04-01)

Reprogramming the tumor-immune landscape via nanomaterial-induced immunogenic cell death: a mini review
by: Xiangwei Meng, et al.
Published: (2025-07-01)

Injectable Nanocomposite Hydrogel for Accelerating Diabetic Wound Healing Through Inflammatory Microenvironment Regulation
by: Chen Y, et al.
Published: (2025-02-01)

Development of anti-cancer drugs for tumor-associated macrophages: a comprehensive review and mechanistic insights
by: Bingjun Bai, et al.
Published: (2024-12-01)

Dual regulation of the cGAS-STING pathway: new targets and challenges for subtype-specific immunotherapy in breast cancer
by: Hanchu Xiong, et al.
Published: (2025-06-01)

Bridging the tumor microenvironment: the pivotal role of cancer-associated fibroblasts in tumor cachexia development
by: Guoming Chen, et al.
Published: (2025-07-01)

Adjunctive beneficial effect of c-di-GMP, a STING agonist, in enhancing protective efficacy of TLR4-adjuvanted tuberculosis subunit vaccine formulations
by: Kee Woong Kwon, et al.
Published: (2025-05-01)

STING Agonist Drug Delivery by Bacterial Extracellular Vesicles Induces Synergistic Immuno‐Oncology Responses and Efficient Inhibition of Tumour Growth
by: Jan Lötvall, et al.
Published: (2025-07-01)

Revisiting TAM polarization: beyond M1- and M2-type TAM toward clinical precision in macrophage-targeted therapy
by: Qingqing Wang, et al.
Published: (2025-09-01)

STING-ΔN, a novel splice isoform of STING, modulates innate immunity and autophagy in response to DNA virus infection
by: Jian Deng, et al.
Published: (2025-06-01)

Investigating the molecular mechanisms and clinical potential of APO+ endothelial cells associated with PANoptosis in the tumor microenvironment of hepatocellular carcinoma using single-cell sequencing data
by: Zhaorui Cheng, et al.
Published: (2025-07-01)

Integrating multi-omics data to optimize immunotherapy in endometrial cancer: a comprehensive study
by: Xin Guan, et al.
Published: (2025-06-01)

Tumor microenvironment responsive Mn-based nanoplatform activate cGAS-STING pathway combined with metabolic interference for enhanced anti-tumor therapy
by: E. Wen, et al.
Published: (2025-05-01)

Gut Microbiota Reshapes the Tumor Microenvironment and Affects the Efficacy of Colorectal Cancer Immunotherapy
by: Fayuan Wang, et al.
Published: (2025-06-01)

Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy
by: Yibo He, et al.
Published: (2025-03-01)

Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity
by: Xiang-mei Wen, et al.
Published: (2025-02-01)

Plant polysaccharides in the regulation of the tumor microenvironment: a review
by: Yuhua Li, et al.
Published: (2025-09-01)

Novel Quaternary Ammonium Salt‐Linked STING Agonist Antibody‐Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off‐Target Toxicity
by: Yu Long, et al.
Published: (2025-08-01)

Carnosic Acid Directly Targets STING C‐Terminal Tail to Improve STING‐Mediated Inflammatory Diseases
by: Wenqing Mu, et al.
Published: (2025-04-01)

Oligonucleotide‐Based Modulation of Macrophage Polarization: Emerging Strategies in Immunotherapy
by: Hanfu Zhang, et al.
Published: (2025-05-01)

Ginkgetin Alleviates Inflammation and Senescence by Targeting STING
by: Yadan Liu, et al.
Published: (2025-01-01)

Enhancing tumor immunotherapy with smart nanoparticles for reprogramming macrophages and blocking the CD47/Sirpα pathway
by: Zubair Hussain, et al.
Published: (2025-06-01)

The role of the microenvironment in tumor growth and spreading
by: V. О. Bitsadze, et al.
Published: (2024-03-01)

Enhanced antitumor efficacy of STING agonist MSA-2 by lipid nanoparticles delivering circular IL-23 mRNA and platinum-modified MSA-2 combination
by: Tian He, et al.
Published: (2025-02-01)

Tumor Associated Macrophages: Evolutionary Role in Cancer Therapeutics
by: Fouzia Fazal, et al.
Published: (2022-07-01)

Synergistic chemo-immunotherapy for osteosarcoma via a pH-responsive multi-component nanoparticle system
by: Dapeng Li, et al.
Published: (2025-04-01)

The human STING agonist E7766 induces immunogenic tumor clearance, independent of tumor-intrinsic STING expression in the KRASG12D/+ Trp53−/− murine model of sarcoma
by: Karys M. Hildebrand, et al.
Published: (2025-12-01)